Published in Brain Res Mol Brain Res on November 26, 2003
DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci U S A (2006) 3.41
NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys (2010) 2.27
Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models. Mitochondrion (2009) 0.98
Edible bird's nest ameliorates oxidative stress-induced apoptosis in SH-SY5Y human neuroblastoma cells. BMC Complement Altern Med (2014) 0.93
L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease. J Neurol (2005) 0.87
Sequential Upregulation of Superoxide Dismutase 2 and Heme Oxygenase 1 by tert-Butylhydroquinone Protects Mitochondria during Oxidative Stress. Mol Pharmacol (2015) 0.83
BTZO-15, an ARE-activator, ameliorates DSS- and TNBS-induced colitis in rats. PLoS One (2011) 0.81
Protective effect of nuclear factor E2-related factor 2 on inflammatory cytokine response to brominated diphenyl ether-47 in the HTR-8/SVneo human first trimester extravillous trophoblast cell line. Toxicol Appl Pharmacol (2014) 0.80
Tert-butylhydroquinone ameliorates doxorubicin-induced cardiotoxicity by activating Nrf2 and inducing the expression of its target genes. Am J Transl Res (2015) 0.75
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. J Gastroenterol (2010) 2.06
Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res (2008) 2.02
Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol (2004) 1.66
Malignant syndrome in Parkinson's disease: concept and review of the literature. Parkinsonism Relat Disord (2003) 1.57
Decreased plasma extracellular superoxide dismutase level in patients with vasospastic angina. Atherosclerosis (2006) 1.47
Experimental hyperhomocysteinemia impairs coronary flow velocity reserve. Int J Cardiol (2005) 1.38
Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med (2007) 1.33
Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun (2008) 1.29
Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance. Clin Biochem (2008) 1.24
Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta (2004) 1.20
Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients. Mol Vis (2009) 1.18
A collaborative study on the malignant syndrome in Parkinson's disease and related disorders. Parkinsonism Relat Disord (2003) 1.11
Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: a randomized, controlled study. Mov Disord (2010) 1.05
Neuferricin, a novel extracellular heme-binding protein, promotes neurogenesis. J Neurochem (2009) 1.04
TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol (2003) 1.02
Neurotrophic activity of neudesin, a novel extracellular heme-binding protein, is dependent on the binding of heme to its cytochrome b5-like heme/steroid-binding domain. J Biol Chem (2007) 1.01
Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures. FEBS Lett (2004) 0.97
Prevention and treatment of malignant syndrome in Parkinson's disease: a consensus statement of the malignant syndrome research group. Parkinsonism Relat Disord (2003) 0.97
Neuroprotection and enhanced recovery with edaravone after acute spinal cord injury in rats. Spine (Phila Pa 1976) (2005) 0.96
A critical role for allograft inflammatory factor-1 in the pathogenesis of rheumatoid arthritis. J Immunol (2007) 0.96
Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications. Diabetes Care (2003) 0.95
Degeneration of dementia with Lewy bodies measured by diffusion tensor imaging. NMR Biomed (2009) 0.95
Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes. Exp Eye Res (2007) 0.94
ER stress inducer, thapsigargin, decreases extracellular-superoxide dismutase through MEK/ERK signalling cascades in COS7 cells. Free Radic Res (2011) 0.93
Extracellular superoxide dismutase overexpression reduces cuff-induced arterial neointimal formation. Atherosclerosis (2005) 0.93
Risk factors for heatstroke among Japanese forestry workers. J Occup Health (2006) 0.93
The effect of hypoxia mimetic cobalt chloride on the expression of EC-SOD in 3T3-L1 adipocytes. Redox Rep (2010) 0.93
Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial. PLoS One (2010) 0.92
[Evaluation of the cardio pulmonary resuscitation/automated external defibrillator class and disability experiences class provided as part of the early exposure program]. Yakugaku Zasshi (2008) 0.92
Nationwide survey of acute juvenile female non-herpetic encephalitis in Japan: relationship to anti-N-methyl-D-aspartate receptor encephalitis. Intern Med (2009) 0.92
Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway. J Neurosci Res (2006) 0.92
Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity. Neurochem Res (2007) 0.91
The effect of tau genotype on clinical features in FTDP-17. Parkinsonism Relat Disord (2005) 0.91
Neudesin, an extracellular heme-binding protein, suppresses adipogenesis in 3T3-L1 cells via the MAPK cascade. Biochem Biophys Res Commun (2009) 0.90
Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy. Neurosci Lett (2005) 0.90
Functions of MAPR (membrane-associated progesterone receptor) family members as heme/steroid-binding proteins. Curr Protein Pept Sci (2012) 0.89
Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease. Int J Cardiol (2008) 0.89
Contribution of hepatocyte nuclear factor-4 to down-regulation of CYP2D6 gene expression by nitric oxide. Mol Pharmacol (2002) 0.89
Enzyme-linked immunosorbent assay of nicotine metabolites. Environ Health Prev Med (2010) 0.88
Cobalt chloride decreases EC-SOD expression through intracellular ROS generation and p38-MAPK pathways in COS7 cells. Free Radic Res (2008) 0.88
Endoplasmic reticulum stress inducers provide protection against 6-hydroxydopamine-induced cytotoxicity. Neurochem Int (2010) 0.87
Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy. Mov Disord (2005) 0.87
Dopaminergic mechanisms controlling urethral function in rats. Neurourol Urodyn (2006) 0.87
Relationship of bladder dysfunction to lesion site in multiple sclerosis. J Urol (2003) 0.87
Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy. Mov Disord (2002) 0.87
Synergistic effect of interleukin-6 promoter (IL6 -634C/G) and intercellular adhesion molecule-1 (ICAM-1 469K/E) gene polymorphisms on the risk of endometriosis in Japanese women. Am J Reprod Immunol (2006) 0.86
Upregulation of vascular extracellular superoxide dismutase in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol (2003) 0.86
Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility. Am J Reprod Immunol (2004) 0.86
Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease. J Gastroenterol (2009) 0.86
Efficacy and safety of extended- versus immediate-release pramipexole in Japanese patients with advanced and L-dopa-undertreated Parkinson disease: a double-blind, randomized trial. Clin Neuropharmacol (2012) 0.86
Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease. Mov Disord (2003) 0.86
Polymorphisms of interferon-gamma gene CA-repeat and interleukin-10 promoter region (-592A/C) in Japanese type I diabetes. Hum Immunol (2002) 0.86
Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Mov Disord (2007) 0.86
Ethanol extract of Brazilian red propolis induces apoptosis in human breast cancer MCF-7 cells through endoplasmic reticulum stress. J Agric Food Chem (2012) 0.85
Suppression of bladder overactivity by adenosine A2A receptor antagonist in a rat model of Parkinson disease. J Urol (2012) 0.85
Effect of atorvastatin on in vitro expression of resistin in adipocytes and monocytes/macrophages and effect of atorvastatin treatment on serum resistin levels in patients with type 2 diabetes. Pharmacology (2005) 0.84
The relationship between exercise-induced oxidative stress and the menstrual cycle. Eur J Appl Physiol (2004) 0.84
TPA induces the expression of EC-SOD in human monocytic THP-1 cells: involvement of PKC, MEK/ERK and NOX-derived ROS. Free Radic Res (2012) 0.84
Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection. Int J Cancer (2009) 0.84
Extracellular-superoxide dismutase expression during monocytic differentiation of U937 cells. J Cell Biochem (2011) 0.84
Heparin-released extracellular superoxide dismutase is reduced in patients with coronary artery atherosclerosis. Atherosclerosis (2005) 0.84
The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes. J Neurol Sci (2010) 0.83
[A guideline for the treatment of Parkinson's disease]. Rinsho Shinkeigaku (2002) 0.83
Roles of adenosine A1 and A2A receptors in the control of micturition in rats. Neurourol Urodyn (2013) 0.83
Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway. Br J Pharmacol (2003) 0.83
Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease. Mov Disord (2003) 0.83
Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci (2003) 0.83
Relationship of serum brain-derived neurotrophic factor level with other markers of disease severity in patients with atopic dermatitis. Clin Immunol (2006) 0.82
Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats. Eur J Pharmacol (2009) 0.82
The effect of heavy metals on nicotinamideN-methyltransferase activityin vitro relating to Parkinson's disease. Environ Health Prev Med (2005) 0.82
Cabergoline stimulates synthesis and secretion of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor by mouse astrocytes in primary culture. Pharmacology (2004) 0.82
Glutathione-S-transferase-1 and interleukin-1beta gene polymorphisms in Japanese patients with Parkinson's disease. Mov Disord (2005) 0.81
Olmesartan improves endothelial function in hypertensive patients: link with extracellular superoxide dismutase. Hypertens Res (2011) 0.81
Zinc-induced modulation of SRSF6 activity alters Bim splicing to promote generation of the most potent apoptotic isoform BimS. FEBS J (2013) 0.81
Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Res Clin Pract (2003) 0.81
Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker. Hypertens Res (2007) 0.81
Alteration of cellular phosphorylation state affects vitamin D receptor-mediated CYP3A4 mRNA induction in Caco-2 cells. Biochem Biophys Res Commun (2002) 0.80
Association of killer cell immunoglobulin-like receptor genotypes with susceptibility to endometriosis. Am J Reprod Immunol (2007) 0.80
Relationship between insulin resistance and inflammatory markers and anti-inflammatory effect of losartan in patients with type 2 diabetes and hypertension. Clin Chim Acta (2006) 0.79
Detection of myelin basic protein in cerebrospinal fluid. Expert Rev Mol Diagn (2002) 0.79
Interferon-gamma gene dinucleotide (CA) repeat and interleukin-4 promoter region (-590C/T) polymorphisms in Japanese patients with endometriosis. Hum Reprod (2004) 0.79
Frequency of anti-AChR epsilon subunit-specific antibodies in MG. Autoimmunity (2003) 0.79
Resistin concentrations in murine adipose tissue and serum measured by a new enzyme immunoassay. Obesity (Silver Spring) (2006) 0.79
Consumption of polyphenol-rich juar tea increases endothelium-bound extracellular superoxide dismutase levels in men with metabolic syndrome: link with LDL oxidizability. Int J Food Sci Nutr (2013) 0.79
Luteolin suppresses the differentiation of THP-1 cells through the Inhibition of NOX2 mRNA expression and the membrane translocation of p47phox. J Nat Prod (2013) 0.79